Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank88
Studio
Year-over-Year Change

Return on equity

Latest
-21.46%
↑ 91% vs avg
Percentile
P88
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-234.39%
Historical baseline
PeriodValueYoY Change
2025-21.46%-436.2%
2024-4.00%+90.3%
2023-41.39%+25.1%
2022-55.23%-44.5%
2021-38.22%+48.6%
2020-74.40%+21.6%
2019-94.86%-121.2%
2018-42.88%+97.5%
2017-1737.07%-